- ChromaDex Announces Nationwide Launch of Tru Niagen® at The Vitamin Shoppe®
- ChromaDex to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
- ChromaDex Announces Inaugural Major Grocery Debut of Tru Niagen® at Sprouts Farmers Market
- ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured™ Transparency Program
- ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024
- ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024
More ▼
Key statistics
As of last trade Chromadex Corp (CDXC:NAQ) traded at 3.46, -25.59% below its 52-week high of 4.65, set on Apr 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.38 |
---|---|
High | 3.52 |
Low | 3.38 |
Bid | 3.44 |
Offer | 3.48 |
Previous close | 3.39 |
Average volume | 333.52k |
---|---|
Shares outstanding | 75.31m |
Free float | 44.29m |
P/E (TTM) | -- |
Market cap | 255.30m USD |
EPS (TTM) | -0.0659 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 18:51 BST.
More ▼